hims glp-1 california & Hers projects $2.3B in 2025 revenue despite uncertainty Hims & Hers launches into

Your appetite is lower, the scale is moving, and youre seeing results

specifics on which labs are included and how often are not detailed on the website Considerations When Comparing Platforms Consider which factors matter most for your specific situation: Medication preference - Do you want oral or injectable

Probiotics: Fact sheet for health professionals

If youre a psychiatrist treating adolescents and young adults, these shifts matter for clinical decision-making and for how board certification and training pathways evolve

This makes them strong options for patients with limited insurance coverage for GLP-1 therapies or those seeking an effective, more cost-conscious alternative

This highlights retatrutides potential to be a highly recommended therapeutic option for achieving clinically meaningful weight loss in individuals with obesity